Learning Objectives:

1. Describe the factors and discussions that are important for treatment decisions in Rheumatology
2. Articulate the pathologic basis for heterogeneity of treatment response in RA
3. Define the newly approved medication therapies for RA and SLE

Session date: 
02/24/2023 - 8:00am to 9:00am CST
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Christina Boutsicaris, MD, RhMSUS